CT-guided intensity-modulated radiotherapy for bladder cancer: Isocentre shifts, margins and their impact on target dose-Reference-Cited by-同舟云学术

CT-guided intensity-modulated radiotherapy for bladder cancer: Isocentre shifts, margins and their impact on target dose

Published:2006-12 Issue:3 Volume:81 Page:276-283
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Redpath Anthony Thomas,Muren Ludvig Paul

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference14 articles.

1. Radical radiotherapy for urinary bladder cancer: treatment outcomes;Fokdal;Expert Rev Anticancer Ther,2006

2. The impact of drinking instructions and bladder outflow measurements on bladder volumes during radiotherapy for bladder cancer (abstr);Lord;Radiother Oncol,2006

3. A model to predict bladder shapes from changes in bladder and rectum filling;Lotz;Med Phys,2004

4. Tumor motion and deformation during external radiotherapy of bladder cancer;Lotz;Int J Radiat Oncol Biol Phys,2006

5. Reproducibility of the bladder shape and bladder shape changes during filling;Lotz;Med Phys,2005

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Therapeutics: Mechanism of Action, Radiation Toxicity, and Drug Formulation;Photoprotective Green Pharmacology: Challenges, Sources and Future Applications;2023

2. Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder;Radiotherapy and Oncology;2021-08

3. A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer;Asian Journal of Urology;2021-07

4. An ultrasound based platform for image-guided radiotherapy in canine bladder cancer patients;Physics and Imaging in Radiation Oncology;2019-10

5. Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy;American Journal of Clinical Oncology;2019-02